Characterization of cellular immune response and innate immune signaling in human and nonhuman primate primary mononuclear cells exposed to Burkholderia mallei - PubMed (original) (raw)
Comparative Study
Characterization of cellular immune response and innate immune signaling in human and nonhuman primate primary mononuclear cells exposed to Burkholderia mallei
Shahabuddin Alam et al. Microb Pathog. 2015 Jan.
Abstract
Burkholderia pseudomallei infection causes melioidosis and is often characterized by severe sepsis. Although rare in humans, Burkholderia mallei has caused infections in laboratory workers, and the early innate cellular response to B. mallei in human and nonhuman primates has not been characterized. In this study, we examined the primary cellular immune response to B. mallei in PBMC cultures of non-human primates (NHPs), Chlorocebus aethiops (African Green Monkeys), Macaca fascicularis (Cynomolgus macaque), and Macaca mulatta (Rhesus macaque) and humans. Our results demonstrated that B. mallei elicited strong primary pro-inflammatory cytokines (IFN-γ, TNF-α, IL-1β, and IL-6) equivalent to the levels of B. pseudomallei in primary PBMC cultures of NHPs and humans. When we examined IL-1β and other cytokine responses by comparison to Escherichia coli LPS, African Green Monkeys appears to be most responsive to B. mallei than Cynomolgus or Rhesus. Characterization of the immune signaling mechanism for cellular response was conducted by using a ligand induced cell-based reporter assay, and our results demonstrated that MyD88 mediated signaling contributed to the B. mallei and B. pseudomallei induced pro-inflammatory responses. Notably, the induced reporter activity with B. mallei, B. pseudomallei, or purified LPS from these pathogens was inhibited and cytokine production was attenuated by a MyD88 inhibitor. Together, these results show that in the scenario of severe hyper-inflammatory responses to B. mallei infection, MyD88 targeted therapeutic intervention may be a successful strategy for therapy.
Keywords: Burkholderia mallei; Burkholderia pseudomallei; Cytokines; Glanders; Immune-pathogenesis; Inflammation; Melioidosis; MyD88.
Published by Elsevier Ltd.
Similar articles
- Comparison of three non-human primate aerosol models for glanders, caused by Burkholderia mallei.
Waag DM, Chance TB, Trevino SR, Rossi FD, Fetterer DP, Amemiya K, Dankmeyer JL, Ingavale SS, Tobery SA, Zeng X, Kern SJ, Worsham PL, Cote CK, Welkos SL. Waag DM, et al. Microb Pathog. 2021 Jun;155:104919. doi: 10.1016/j.micpath.2021.104919. Epub 2021 Apr 27. Microb Pathog. 2021. PMID: 33915206 - Development of Burkholderia mallei and pseudomallei vaccines.
Silva EB, Dow SW. Silva EB, et al. Front Cell Infect Microbiol. 2013 Mar 11;3:10. doi: 10.3389/fcimb.2013.00010. eCollection 2013. Front Cell Infect Microbiol. 2013. PMID: 23508691 Free PMC article. Review. - Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.
Moustafa DA, Scarff JM, Garcia PP, Cassidy SK, DiGiandomenico A, Waag DM, Inzana TJ, Goldberg JB. Moustafa DA, et al. PLoS One. 2015 Jul 6;10(7):e0132032. doi: 10.1371/journal.pone.0132032. eCollection 2015. PLoS One. 2015. PMID: 26148026 Free PMC article. - Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis.
Khakhum N, Bharaj P, Myers JN, Tapia D, Walker DH, Endsley JJ, Torres AG. Khakhum N, et al. PLoS Negl Trop Dis. 2019 Jul 15;13(7):e0007578. doi: 10.1371/journal.pntd.0007578. eCollection 2019 Jul. PLoS Negl Trop Dis. 2019. PMID: 31306423 Free PMC article. - Glanders: off to the races with Burkholderia mallei.
Whitlock GC, Estes DM, Torres AG. Whitlock GC, et al. FEMS Microbiol Lett. 2007 Dec;277(2):115-22. doi: 10.1111/j.1574-6968.2007.00949.x. FEMS Microbiol Lett. 2007. PMID: 18031330 Review.
Cited by
- A reverse-phase protein microarray-based screen identifies host signaling dynamics upon Burkholderia spp. infection.
Chiang CY, Uzoma I, Lane DJ, Memišević V, Alem F, Yao K, Kota KP, Bavari S, Wallqvist A, Hakami RM, Panchal RG. Chiang CY, et al. Front Microbiol. 2015 Jul 27;6:683. doi: 10.3389/fmicb.2015.00683. eCollection 2015. Front Microbiol. 2015. PMID: 26284031 Free PMC article. - An increase in intracellular p62/NBR1 and persistence of Burkholderia mallei and B. pseudomallei in infected mice linked to autophagy deficiency.
Saikh KU, Dankmeyer JL, Zeng X, Ulrich RG, Amemiya K. Saikh KU, et al. Immun Inflamm Dis. 2019 Mar;7(1):7-21. doi: 10.1002/iid3.239. Epub 2018 Dec 19. Immun Inflamm Dis. 2019. PMID: 30569531 Free PMC article. - The Innate Immune Response in the Marmoset during the Acute Pneumonic Disease Caused by Burkholderia pseudomallei.
Ngugi S, Laws T, Simpson AJ, Nelson M. Ngugi S, et al. Infect Immun. 2022 Mar 17;90(3):e0055021. doi: 10.1128/IAI.00550-21. Epub 2022 Jan 18. Infect Immun. 2022. PMID: 35041487 Free PMC article. - Innate immune response to Burkholderia mallei.
Saikh KU, Mott TM. Saikh KU, et al. Curr Opin Infect Dis. 2017 Jun;30(3):297-302. doi: 10.1097/QCO.0000000000000362. Curr Opin Infect Dis. 2017. PMID: 28177960 Free PMC article. Review. - Bacterial overgrowth and diversification of microbiota in gastric cancer.
Wang L, Zhou J, Xin Y, Geng C, Tian Z, Yu X, Dong Q. Wang L, et al. Eur J Gastroenterol Hepatol. 2016 Mar;28(3):261-6. doi: 10.1097/MEG.0000000000000542. Eur J Gastroenterol Hepatol. 2016. PMID: 26657453 Free PMC article.